An interventional study of narrative medicine training combined with CBL training and CBL training in Narrative Medicine and Case-based Learning, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Completed at 1 site in China. Open to participants aged 24 Years to 28 Years. Per ClinicalTrials.gov, last updated 2024-05-31.
Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This was a prospective, longitudinal, single-center nonrandomized controlled study. A total of 36 first- and second-year general practice residents of Zhejiang University School of Medicine were voluntarily enrolled in the experimental group. The remaining 9 residents served as a control group. The experimental group received narrative medicine training combined with CBL training. The control group received normal CBL training. None of the participants had previously had any training in narrative medicine. Teaching evaluation scores were measured for all subjects at baseline and 1 year after the training.
20 studies on the registry are indexed under Narrative Medicine; 8 are open to participants now.
This study's enrollment of 45 is below the median of 60 across 12 interventional studies indexed under Narrative Medicine.
Browse Narrative Medicine studies →Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,042 studies on the registry; 499 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The experimental group received narrative medicine training combined with CBL training
Behavioral: narrative medicine training combined with CBL training
The control group received normal CBL training
Behavioral: CBL training
The experimental group received narrative medicine training combined with CBL training.
The control group received normal CBL training.
Satisfaction Survey of Residents in the Experimental Group
The satisfaction survey was divided into five levels, ranging from "strongly agree" to "strongly disagree". The higher percent of agree means better result.
Time frame: 12 months
Comparison of the SEGUE scale scores Between the Experimental Group and the Control Group
The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.
Time frame: 12 months
Comparison of the JSE-S scale scores Between the Experimental Group and the Control Group
The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.
Time frame: 12 months
Comparison of the SEGUE scale in Different Grades Before and After Training in the Experimental Group
The SEGUE scale scores were generated by assigning a value of "1" for "yes", "0" for "no" and "0.5" for "cannot answer". High scores indicate stronger clinical communication skills.
Time frame: 12 months
Comparison of the JSE-S scale in Different Grades Before and After Training in the Experimental Group
The JSE-S scale scores adopts a 7-point Likert scale ranging from "strongly disagree" to "strongly agree". The higher total score indicating a greater level of empathy.
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2022 to primary completion in Dec 2023, 17 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital, School of Medicine, Zhejiang University →